Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B Cells-Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02053220
What this trial is testing

Mechanism of Action Trial of ColoAd1

Who this might be right for
Resectable Colon CancerResectable Non-small Cell Lung CancerResectable Bladder Cancer+1 more
Akamis Bio 17
Testing effectiveness (Phase 2)WithdrawnNCT01131247
What this trial is testing

PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & Ofatumumab

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
Nevada Cancer Institute 37
Large-scale testing (Phase 3)Study completedNCT01892618
What this trial is testing

Pneumococcal Vaccine in Untreated CLL Patients

Who this might be right for
Chronic Lymphocytic Leukemia
Karolinska University Hospital 134
Early research (Phase 1)UnknownNCT04289220
What this trial is testing

Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia

Who this might be right for
B Cell LymphomaB-cell Acute Lymphoblastic Leukemia
Yan'an Affiliated Hospital of Kunming Medical University 10
Testing effectiveness (Phase 2)Study completedNCT04883749
What this trial is testing

Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL

Who this might be right for
Chronic Lymphoid Leukemia
German CLL Study Group 53
Testing effectiveness (Phase 2)Ended earlyNCT04730349
What this trial is testing

Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer

Who this might be right for
EpendymomaEwing SarcomaHigh-grade Glioma+7 more
Bristol-Myers Squibb 15
Testing effectiveness (Phase 2)Looking for participantsNCT05633615
What this trial is testing

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaGrade 3b Follicular LymphomaPrimary Mediastinal (Thymic) Large B-Cell Lymphoma+4 more
SWOG Cancer Research Network 396
Early research (Phase 1)Active Not RecruitingNCT04884035
What this trial is testing

Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

Who this might be right for
Lymphoma, B-Cell
Celgene 224
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07776717
What this trial is testing

TACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Clear Cell Renal Cell CarcinomaAdvanced Clear Cell Renal Cell Carcinoma
Fudan University 30
Post-approval studies (Phase 4)UnknownNCT01949818
What this trial is testing

Treatment of Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Mingzhi Zhang 120
Early research (Phase 1)Looking for participantsNCT05098613
What this trial is testing

Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients

Who this might be right for
Non-Hodgkin LymphomaB-cell Non-Hodgkin Lymphoma (B-NHL)Mantle Cell Lymphoma (MCL)+1 more
University of Colorado, Denver 68
Testing effectiveness (Phase 2)Study completedNCT02348216
What this trial is testing

Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Refractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed Diffuse Large B-Cell LymphomaTransformed Follicular Lymphoma (TFL)+2 more
Kite, A Gilead Company 307
Testing effectiveness (Phase 2)Looking for participantsNCT06697184
What this trial is testing

Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Who this might be right for
Chronic Lymphocytic LeukemiaCLLMantle Cell Lymphoma+1 more
BeOne Medicines 258
Testing effectiveness (Phase 2)UnknownNCT03265106
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects

Who this might be right for
Relapsed B-cell Acute Lymphoblastic Leukemia, ChildhoodRefractory B-cell Acute Lymphoblastic Leukemia, ChildhoodRelapsed/Refractory B-cell Lymphoma, Childhood
Shenzhen BinDeBio Ltd. 20
Early research (Phase 1)Not Yet RecruitingNCT07068906
What this trial is testing

A Clinical Study Exploring CT1194C in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 27
Testing effectiveness (Phase 2)Study completedNCT00559104
What this trial is testing

Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 60
Large-scale testing (Phase 3)Study completedNCT00137995
What this trial is testing

R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

Who this might be right for
Lymphoma, Large-Cell, Diffuse
Lymphoma Study Association 481
Very early researchLooking for participantsNCT07695012
What this trial is testing

CAR-T Cell Therapy for ALL

Who this might be right for
Relapsed Acute Lymphoblastic Leukemia (ALL)
Dr. Zaineb Akram 10
Testing effectiveness (Phase 2)Ended earlyNCT01235793
What this trial is testing

The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma

Who this might be right for
B-Cell Lymphoma Originating in the CNS
Cedars-Sinai Medical Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT04941716
What this trial is testing

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia+1 more
Fred Hutchinson Cancer Center 20
Next Page